Helixbind Inc

Closed
Call
Website
181 Cedar Hill St Ste 1
Marlborough, MA 01752
+1 (508) 460-1028
https://www.helixbind.com

HelixBind Inc., based in Boxborough, MA, is at the forefront of revolutionizing diagnostics for bloodstream infections through its innovative platform that delivers faster, more accurate, and informative microbiology results. By enabling precise identification of invasive infections, HelixBind aims to support clinicians in developing personalized antimicrobial therapies, ultimately improving patient outcomes and combating the rise of antimicrobial resistance.

Addressing the urgent challenge of sepsis—which accounts for 1.7 million cases annually in the US and over 30 million globally—HelixBind significantly reduces the turnaround time for diagnostic results. Their technology provides key insights in just four hours, compared to traditional blood cultures that take 2-3 days, allowing healthcare providers to initiate effective treatment promptly.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Services, nec, nec, Business services, nec, nec, Blood derivatives

Bio Physics Assay Lab Inc

BioPhysics Assay Lab Inc., located in Worcester, MA, specializes in the development and commercialization of innovative tools for the life science and biomedical communities. The company offers an array of unique products, including kidney diagnostics, MRI contrast agents, and specialized chemical solutions, aimed at enhancing measurement techniques in various scientific fields. Among its offerings are immunoassay kits for renal function measurement, novel MRI contrast reagents, and pioneering in vivo diagnostic products using neutron activation technology. BioPAL is committed to providing solutions that cater specifically to the needs of researchers and professionals in the life sciences sector. Generated from the website
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Blood derivatives, Physicians' office, including specialists, Business services, nec, nec

Avant Immunotherapeutics

Avant Immunotherapeutics, located in Needham Heights, MA, is pioneering advancements in immunology with a focus on delivering transformative therapies for patients. Their lead program, barzolvolimab, is a humanized monoclonal antibody designed to target KIT, a key receptor involved in severe inflammatory, allergic, and autoimmune diseases. Leveraging extensive expertise in developing antibody-based immunotherapies, Avant Immunotherapeutics utilizes robust in-house capabilities to optimize the discovery and development of innovative scientific programs. The company remains committed to improving patient outcomes through their advanced therapeutic approaches. Generated from the website
United States›Massachusetts›Marlborough›Helixbind Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.